HCAT Earnings

Quarterly EPS
$-0.24
Q3 2024
$-0.33
Q4 2024
$-0.35
Q1 2025
$-0.59
Q2 2025
$-0.32
Q3 2025
$-1.28
Q4 2025
$-1.53
Q1 2026
$-0.55
Q2 2026
Latest Revenue70.5M
Latest Net Income-40537000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.5570.5M-40537000-12.7%+6.8%
Q1 2026-$1.5370.8M-111026000-10.9%-337.1%
Q4 2025-$1.2874.7M-91025000-6.2%-287.9%
Q3 2025-$0.3276.3M-22229000-0.0%-33.3%
Q2 2025-$0.5980.7M-40978000+6.3%-156.5%
Q1 2025-$0.3579.4M-23742000+6.3%+0.0%
Q4 2024-$0.3379.6M-20673000+6.0%+37.7%
Q3 2024-$0.2476.4M-14726000+3.5%+38.5%
Q2 2024-$0.2375.9M-13516000
Q1 2024-$0.3574.7M-20587000
Q4 2023-$0.5375.1M-30312000
Q3 2023-$0.3973.8M-22032000
Health Catalyst (HCAT) — Earnings